(Q45168592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Anne Lienhart

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Claude Negrier

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

C Prevost

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

J Claude Bordet

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

957-961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

High dose factor VIIa improves clot structure and stability in a model of haemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Thrombin generation and fibrin clot structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Calibrated automated thrombin generation measurement in clotting plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Plasma and cellular contributions to fibrin network formation, structure and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Influence of cellular and plasma procoagulant activity on the fibrin network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02526.X

10.1111/J.1365-2516.2011.02526.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453422%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference